Viewing Study NCT00215995


Ignite Creation Date: 2025-12-24 @ 1:58 PM
Ignite Modification Date: 2026-02-03 @ 12:29 AM
Study NCT ID: NCT00215995
Status: COMPLETED
Last Update Posted: 2012-01-13
First Post: 2005-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None esophageal cancer View
None esophagogastric cancer View
None gastric cancer View